Corrigendum: RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion (Front. Oncol., (2021), 11, 10.3389/fonc.2021.665273)

Fang He, Yoshinori Matsumoto, Yosuke Asano, Yuriko Yamamura, Takayuki Katsuyama, Jose La Rose, Nahoko Tomonobu, Ni Luh Gede Yoni Komalasari, Masakiyo Sakaguchi, Robert Rottapel, Jun Wada

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original article, there was a mistake in Figures 1A, B, D, F, 2D, 3B–D, F, 4D, S5A as published. We noticed that several qPCR data were not correctly normalized since the calculation program of the DCt method did not work. The corrected Figures 1A, B, D, F, 2D, 3B–D, F, 4D, S5A and the equivalent raw data in Figures S1–S4 and S5A appears below. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number729192
JournalFrontiers in Oncology
Volume11
DOIs
Publication statusPublished - Jul 20 2021

Keywords

  • ABL—Abelson murine leukemia viral oncogene homolog
  • Runx2 (runt-related transcription factor 2)
  • invasion
  • phosphorylation
  • tyrosine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum: RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion (Front. Oncol., (2021), 11, 10.3389/fonc.2021.665273)'. Together they form a unique fingerprint.

Cite this